EZH2, enhancer of zeste 2 polycomb repressive complex 2 subunit, 2146
N. diseases: 653; N. variants: 35
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 7 | 148828812 | missense variant | C/G | snv | 7.8E-02 | 6.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.080 | 7 | 148828812 | missense variant | C/G | snv | 7.8E-02 | 6.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |